Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.
A move toward a more inclusive society
By
Lois A. Bowers
Apr 03, 2017
What do dementia and Parkinson’s disease have to do with professional basketball? Read on.
Dementia: Detection possible 9 years before diagnosis and could lead to earlier interventions, researchers...
By
Kimberly Bonvissuto
Oct 18, 2022
Detecting signs of dementia up to nine years before diagnosis is possible and could lead to earlier interventions to reduce development of the disease and help recruit people to participate in clinical...
Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Dementia drug helps prevent falls in those with Parkinson’s
By
Lois A. Bowers
Jan 13, 2016
A drug commonly prescribed to treat symptoms of dementia could help prevent falls for people with Parkinson’s disease, according to new research.
Speech therapy giant expands access for seniors via telehealth partnership
By
Aaron Dorman
Aug 25, 2023
A new partnership between a speech therapy platform and a telehealth provider will expand offerings of speech therapy programs for seniors.
More news for Thursday, June 1
May 31, 2017
Mobility aids may increase fall risk for those with dementia … Handwashing: Cool water as effective as hot for removing germs … Infection with seasonal flu may increase risk of developing Parkinson’s...
More news for Friday, June 16
Jun 15, 2017
Alzheimer’s affects twice as many people as estimated … Statins may not be used for protection against Parkinson’s disease … Liquid laundry detergent pods pose lethal risk for adults...
Anticholinergic drugs don’t raise dementia risk in those with Parkinson’s
By
Lois A. Bowers
Jan 05, 2016
Concern that anticholinergic drugs could potentially worsen cognition in those with Parkinson’s disease are unfounded, according to new research reported in the Journal of Parkinson’s Disease.
More news for Monday, Jan. 22
By
Kimberly Bonvissuto
Jan 22, 2024
Boosting CNA workforce is focus of state association campaign … Tracking conditions in older adults may help ID those at risk of cognitive impairment … Hackers stole $7.5M from HHS, leaving grant recipients...